Avid Bioservices Inc (CDMO)

[EYEBUYSTOX]

Bingo Threes...King would NEVER hype a trial if he didn't think it was the real deal. I share your prior frustrations thinking that PR opportunities were missed, but in hindsight when the trials weren't gold standard there would have also been ample opportunity for shorts/other interests, etc. to pick holes in the data.

Now that the trial design is above and beyond scrutiny and the results are in, the confidence is oozing from the voices of PPHM executives and it's the main thing keeping a smile on my face every single day. It really makes me proud that I was able to sit through all of the dilution and boring CCs to see this thing to the next phase of development. Exciting times for sure.

It's still amazes me that INHX was bought for 2.5 billion on early phase clinical trial data...unreal.